1
TÍTULO: REAL-WORLD OUTCOMES IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION AND SUBSTANCE ABUSE DISORDERS TREATED WITH GLECAPREVIR/PIBRENTASVIR FOR 8 WEEKS: A POOLED ANALYSIS OF MULTINATIONAL POST-MARKETING OBSERVATIONAL STUDIES  Full Text
AUTORES: Giuliano Rizzardini; Michael Gschwantler; Stefan Bourgeois; Beat Mullhaupt; Wlodzimierz Mazur; Mark Bondin; Zhenzhen Z Zhang; Fiona Marra; Ella Veitsman; Konstantinos Mimidis; Nuno Marques; Juliette Foucher;
PUBLICAÇÃO: 2020, FONTE: Liver Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) in HEPATOLOGY, VOLUME: 72
INDEXADO EM: WOS
2
TÍTULO: Integrating public health policies in the epidemiological modeling of hepatitis C with LEHC tool: application in Austria  Full Text
AUTORES: Henrique Lopes; Ricardo Baptista Leite; Diogo Franco; Roxana Pirker; Michael Gschwantler;
PUBLICAÇÃO: 2020, FONTE: WIENER KLINISCHE WOCHENSCHRIFT
INDEXADO EM: Scopus WOS
3
TÍTULO: Time to Viral Suppression is Not Related to Achievement of SVR12 in HCV GT1-infected Patients Treated with ABT-450/r/Ombitasvir and Dasabuvir With or Without Ribavirin
AUTORES: Mark S Sulkowski; Michael W Fried; Resat Ozaras; Vasily Isakov; David L Wyles; Peter Ferenci; Jordan J Feld; Filipe Calinas; Michael Gschwantler; Martin King; Tolga Baykal; Edward J Gane;
PUBLICAÇÃO: 2014, FONTE: 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases in HEPATOLOGY, VOLUME: 60
INDEXADO EM: WOS